← Back to Search

Procedure

TOETVA for Thyroid Disease

Phase 1
Waitlist Available
Led By Jesse D Pasternak, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial is testing a new type of thyroid surgery done through the mouth instead of making a cut in the neck. It targets adults who need thyroid or parathyroid surgery. The goal is to see if this method is safe and practical. This new approach has been developed to avoid visible scars and improve patient satisfaction.

Eligible Conditions
  • Thyroid Disease
  • Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Length of stay
Neck incision
Post-operative recurrent laryngeal nerve palsy
+8 more
Secondary study objectives
Quality of Life Score

Trial Design

1Treatment groups
Experimental Treatment
Group I: TOETVAExperimental Treatment1 Intervention
Transoral Endoscopic Thyroidectomy Vestibular Approach
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TOETVA
2019
N/A
~20

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,514 Previous Clinical Trials
500,190 Total Patients Enrolled
Jesse D Pasternak, MDPrincipal InvestigatorUniversity Health Network, Toronto
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top